We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

113 hedge funds and large institutions have $571M invested in Dyne Therapeutics in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,655% more call options, than puts

Call options by funds: $860K | Put options by funds: $49K

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

11% more funds holding

Funds holding: 102 → 113 (+11)

7.82% more ownership

Funds ownership: 87.56% → 95.38% (+7.8%)

9% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% less capital invested

Capital invested by funds: $573M → $571M (-$1.79M)

Holders
113
Holders Change
+11
Holders Change %
+10.78%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
37
Reduced
34
Closed
9
Calls
$860K
Puts
$49K
Net Calls
+$811K
Net Calls Change
+$304K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$26.9M
2
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
+$10.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.8M
4
Goldman Sachs
Goldman Sachs
New York
+$5.07M
5
Axa
Axa
France
+$4.27M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$19.5M
2
DTC
Deep Track Capital
Connecticut
-$5.79M
3
UOC
UBS O'Connor
Illinois
-$2.24M
4
LGM
Logos Global Management
California
-$1.59M
5
Citigroup
Citigroup
New York
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$3.36M +$798K +68,945 +31%
Northern Trust
27
Northern Trust
Illinois
$3.26M +$167K +14,454 +5%
ACH
28
ArrowMark Colorado Holdings
Colorado
$3.19M – – –
Assenagon Asset Management
29
Assenagon Asset Management
Luxembourg
$3.05M – – –
Millennium Management
30
Millennium Management
New York
$2.94M +$1.99M +172,159 +210%
Charles Schwab
31
Charles Schwab
California
$2.64M +$66K +5,708 +3%
Norges Bank
32
Norges Bank
Norway
$1.83M +$1.83M +157,752 New
Two Sigma Investments
33
Two Sigma Investments
New York
$1.8M +$1.6M +138,325 +813%
AG
34
Algert Global
California
$1.78M -$16.8K -1,450 -0.9%
N
35
Nuveen
North Carolina
$1.69M -$184K -15,885 -10%
Invesco
36
Invesco
Georgia
$1.56M -$34.2K -2,959 -2%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.48M +$89.4K +7,729 +6%
MIM
38
Monashee Investment Management
Massachusetts
$1.43M -$883K -76,281 -38%
Renaissance Technologies
39
Renaissance Technologies
New York
$1.25M +$32.4K +2,800 +3%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$1.24M +$779K +67,300 +168%
HMC
41
Harvard Management Company
Massachusetts
$1.24M – – –
HS
42
HighVista Strategies
Massachusetts
$1.19M – – –
Jane Street
43
Jane Street
New York
$1.11M +$1.11M +95,751 New
AAA
44
Affinity Asset Advisors
New York
$1.07M +$1.07M +92,170 New
Wellington Management Group
45
Wellington Management Group
Massachusetts
$904K -$50.7K -4,380 -5%
Ohio Public Employees Retirement System (OPERS)
46
Ohio Public Employees Retirement System (OPERS)
Ohio
$900K -$141K -12,174 -14%
Morgan Stanley
47
Morgan Stanley
New York
$747K -$753K -65,110 -50%
Swiss National Bank
48
Swiss National Bank
Switzerland
$724K +$19.7K +1,700 +3%
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
$698K +$394K +34,057 +130%
RJA
50
Raymond James & Associates
Florida
$642K -$32.9K -2,840 -5%
1
2
3 4 5

DYN Hedge Fund Activity: Q4 2022 in Review

113 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2022, worth a combined $571M — down 0.31% from $573M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DYN positions and 9 closed out — a net gain of 12 holders — while 37 added to existing stakes and 34 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $26.9M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $19.5M sold.

  • 113 institutional investors held Dyne Therapeutics (DYN) as of Q4 2022, up from 102 in Q3 2022.
  • Funds reported $571M of Dyne Therapeutics stock for Q4 2022, down 0.31% quarter-over-quarter.
  • 21 funds opened new Dyne Therapeutics positions in Q4 2022 and 9 closed out, a net change of +12 holders.
  • The largest Dyne Therapeutics buyer in Q4 2022 was EcoR1 Capital, an estimated $26.9M added.
  • The largest Dyne Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $19.5M sold.

Based on aggregated 13F filings for Q4 2022.